Search Results

Gedatolisib 2 mg  | Purity Not Available

TargetMol

Gedatolisib is a highly effective dual inhibitor targeting the PI3Kα/γ (IC50: 0.4/5.4 nM)and mTOR (IC50: 1.6 nM) in the PI3K/mTOR signaling pathway.

More Information Supplier Page

Dinaciclib 2 mg  | 99.73%

TargetMol

Dinaciclib is a new-type and effective CDK inhibitor for CDK2/5/1/9 (IC50: 1 nM/1 nM/3 nM/4 nM) with potential antineoplastic activity.

More Information Supplier Page

Tiratricol 100 mg  | 99.60%

TargetMol

Tiratricol is a metabolite of T3 and T4 thyroid hormones; promoted for hyperlipidemia, localized lipodystrophy, and obesity. Tiratricol has been used in trials studying the treatment of Allan-Herndon-Dudley Syndrome.

More Information Supplier Page

Thiamphenicol 100 mg  | Purity Not Available

TargetMol

Thiamphenicol is a methylsulfonyl analog of chloramphenicol. It is an antibiotic and immunosuppressive agent.

More Information Supplier Page

Rizatriptan benzoate 200 mg  | 99.00%

TargetMol

Rizatriptan benzoate selectively binds to and activates serotonin (5-HT) 1B receptors and 5-HT 1D receptors providing relief of migraine headaches.

More Information Supplier Page

Meclofenoxate hydrochloride 100 mg  | 99.04%

TargetMol

Meclofenoxate hydrochloride is an ester of DIMETHYLAMINOETHANOL and para-chlorophenoxyacetic acid. It has been shown to improve memory and general cognition, and mentally stimulating effect.

More Information Supplier Page

Tiratricol 200 mg  | 99.60%

TargetMol

Tiratricol is a metabolite of T3 and T4 thyroid hormones; promoted for hyperlipidemia, localized lipodystrophy, and obesity. Tiratricol has been used in trials studying the treatment of Allan-Herndon-Dudley Syndrome.

More Information Supplier Page